Read the leaked First Round Capital letter to its limited partners - Philly


Jul. 8, 2015 9:29 am

Read the leaked First Round Capital letter to its limited partners

Josh Kopelman explains why First Round Capital isn't going to increase its fund size, despite the current abundance of capital for seed-stage funds.

First Round Capital's Josh Kopelman at Startup Grind Philadelphia, November 2014.

(Photo by Jason Sherman)

Even though the venture capital world is in a frenzy — valuations are ballooning, more and more so-called “unicorns” are appearing every day — First Round Capital is staying the course.

That was the message managing partner Josh Kopelman sent in May to his venture capital firm’s limited partners in his quarterly letter. It was leaked this week, racking up nearly 55,000 views on Scribd.

Read the letter

Here’s Kopelman explaining his strategy:


He continued: “So even though there’s almost a 10x increase in the availability of capital for seed-stage funds right now, we’ve chosen not to materially increase our fund size (our current fund is just 2.8% larger than our prior fund).”

He also noted that it’s been First Round’s slowest two quarters in six years, making just 10 investments since Q4 2014.

“We don’t expect that our pace will permanently remain this low — already one month into Q2, we’ve seen an uptick in new investments,” he wrote.

Find more analysis here on the newly paywalled PandoDaily, which happens to be backed personally by Kopelman.


Already a member? Sign in here


A 3D geospatial product is spinning out as its own company with $5M Series A raise

How Macquarie blends tech-fueled financial services with global opportunity

This North Philly-based ‘ugly’ produce startup just raised $16.5M



Why Linode sent this manager to Mumbai for 7 months

Ambler, PA


Data Engineer

Apply Now
Center City


Member Experience Specialist

Apply Now
Philadelphia, PA


Frontend Engineer

Apply Now

Why Ben Franklin Technology Partners is fighting for more state funding

Old City medtech startup Strados Labs set to hire after raising $1.8M

Biotech company Chondrial Therapeutics has raised $25.8M for its Friedreich’s ataxia treatment



This financial services firm offers global opportunity in the heart of Philly



UX Designer

Apply Now
Horsham, PA

Penn Mutual

Software Engineer-Java

Apply Now

The Philadelphia Inquirer

Mobile Tech Lead

Apply Now

Sign-up for daily news updates from Philadelphia

Do NOT follow this link or you will be banned from the site!